Health Care & Life Sciences » Biotechnology | SciVision Biotech Inc.

SciVision Biotech Inc. | Balance Sheet

Fiscal year is January-December. All values TWD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
865
706
437
474
346
385
Total Accounts Receivable
19
25
66
47
55
74
Inventories
73
65
49
34
33
42
Other Current Assets
8
15
13
31
15
22
Total Current Assets
963
811
566
587
450
524
Net Property, Plant & Equipment
121
238
441
664
1,008
1,082
Total Investments and Advances
8
7
22
51
51
40
Intangible Assets
1
1
1
7
6
6
Other Assets
2
-
-
1
4
4
Total Assets
1,129
1,092
1,073
1,357
1,563
1,696
ST Debt & Current Portion LT Debt
5
1
2
84
78
Accounts Payable
2
2
7
11
4
Income Tax Payable
-
-
-
-
-
Other Current Liabilities
19
40
59
93
102
Total Current Liabilities
25
43
68
188
184
Long-Term Debt
-
-
25
229
422
Provision for Risks & Charges
18
24
29
33
33
Deferred Taxes
35
35
43
48
45
Other Liabilities
2
2
2
12
9
Total Liabilities
45
69
124
463
649
Common Equity (Total)
1,084
1,023
949
894
914
Total Shareholders' Equity
1,084
1,023
949
894
914
Total Equity
1,084
1,023
949
894
914
Liabilities & Shareholders' Equity
1,129
1,092
1,073
1,357
1,563

About SciVision Biotech

View Profile
Address
9 South 6th Road
Kaohsiung City KH 806 81
Taiwan
Employees -
Website http://www.scivision.com.tw
Updated 07/08/2019
SciVision Biotech, Inc. engages in the research, development, and production of hyaluronic acid medical products. Its products include dermis and joint injection, skin care cream and masks, and glucosamine tablets. The company was founded on November 12, 2001 and is headquartered in Kaohsiung, Taiwan.